Correction to: Drug tolerability and reasons for discontinuation of seven biologics in 4466 treatment courses of rheumatoid arthritis-the ANSWER cohort study

Affiliations

• ¹ Department of Orthopaedic Surgery, Osaka University, Graduate School of Medicine, Osaka, Japan. [email protected].
• ² Department of Advanced Medicine for Rheumatic Diseases, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
• ³ Department of Health Information Management, Kurashiki Sweet Hospital, Kurashiki, Japan.
• ⁴ Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Osaka, Japan.
• ⁵ The Center for Rheumatic Diseases, Nara Medical University, Nara, Japan.
• ⁶ Department of Rheumatology, Osaka Red Cross Hospital, Osaka, Japan.
• ⁷ Department of Rheumatology and Clinical Immunology, Kobe University Graduate School of Medicine, Kobe, Japan.
• ⁸ Department of Internal Medicine (IV), Osaka Medical College, Osaka, Japan.
• ⁹ First Department of Internal Medicine, Kansai Medical University, Osaka, Japan.
• ¹⁰ Department of Medical Informatics, Wakayama Medical University Hospital, Wakayama, Japan.
• ¹¹ Department of Orthopaedic Surgery, Osaka University, Graduate School of Medicine, Osaka, Japan.